DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl  1     Casper Steenholdt  1     Jens Frederik Dahlerup  2     Tobias Wirenfeldt Klausen  1     Mark Andrew Ainsworth  3     Jørgen Jahnsen  4     Jørn Brynskov  5     Ole Østergaard Thomsen     Katrine Risager Christensen     Akbar Molazahi     Natalia Pedersen     Niels Thorsgaard     Eva Efsen Dahl     Ida Vind     Hendrika Adriana Linda Kievit     Taina Sipponen     Jan Marsal;;    
1 Copenhagen University Hospital at Herlev,Herlev,Denmark
2 Aarhus University Hospital,Aarhus,Denmark
3 Odense University Hospital,Odense,Denmark
4 Akershus University Hospital,Lørenskog,Norway
5 Copenhagen University Hospital

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing